(Q46477760)

22 December 2017

title

Personalizing medicine for autoimmune and inflammatory diseases (English)

1 reference

22 December 2017

author name string

Andrew C Chan

series ordinal

1

1 reference

22 December 2017

Timothy W Behrens

series ordinal

2

1 reference

22 December 2017

language of work or name

English

0 references

publication date

1 February 2013

1 reference

22 December 2017

published in

Nature Immunology

1 reference

22 December 2017

volume

14

1 reference

22 December 2017

issue

2

1 reference

22 December 2017

page(s)

106-109

1 reference

22 December 2017

Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug

cites work

1 reference

Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer

21 January 2018

1 reference

Asthma phenotypes: the evolution from clinical to molecular approaches

21 January 2018

1 reference

A large-scale, consortium-based genomewide association study of asthma

21 January 2018

1 reference

T-helper type 2-driven inflammation defines major subphenotypes of asthma.

21 January 2018

1 reference

Lebrikizumab treatment in adults with asthma

21 January 2018

1 reference

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

21 January 2018

1 reference

A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus

21 January 2018

1 reference

Belimumab reduces autoantibodies, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosus

21 January 2018

1 reference

Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice

21 January 2018

1 reference

Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus

21 January 2018

1 reference

Interferon and granulopoiesis signatures in systemic lupus erythematosus blood

21 January 2018

1 reference

Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease.

21 January 2018

1 reference

Common variants at five new loci associated with early-onset inflammatory bowel disease

21 January 2018

1 reference

The intestinal microbiota in inflammatory bowel diseases: time to connect with the host

21 January 2018

1 reference

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

21 January 2018

1 reference

Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial

21 January 2018

1 reference

A randomized trial of Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease

21 January 2018

1 reference

Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23334822

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma–Summary Report 2007

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NI.2473

1 reference

22 December 2017

1 reference

22 December 2017